Clinical Trial Update: Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rivaroxaban to warfarin for progression of coronary calcium in patients with atherosclerosis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Warfarin (warfarin)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Atherosclerosis | Phase 4 | Status: COMPLETED | Results posted: 2021-07-22